• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体器官移植受者中产超广谱β-内酰胺酶(ESBLs)的多重耐药革兰氏阴性杆菌及ESBL基因的患病率。

Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.

作者信息

Men T-Y, Wang J-N, Li H, Gu Y, Xing T-H, Peng Z-H, Zhong L

机构信息

Department of Urology, Shandong University Affiliated Shandong Province Qianfoshan Hospital, Jinan, China.

出版信息

Transpl Infect Dis. 2013 Feb;15(1):14-21. doi: 10.1111/tid.12001. Epub 2012 Sep 26.

DOI:10.1111/tid.12001
PMID:23013385
Abstract

BACKGROUND

Multidrug-resistant (MDR) gram-negative bacilli pose a serious and rapidly emerging threat to recipients of solid organ transplants (SOTs). However, extended-spectrum β-lactamases (ESBLs), as one of the cardinal mechanisms of resistance to antimicrobial agents in SOT recipients, remain obscure. The aim of this study was to investigate the prevalence of strains producing ESBLs in SOT patients with MDR gram-negative bacilli infections and to identify the ESBL genes carried by them.

MATERIALS AND METHODS

Isolates from various clinical specimens of SOT recipients were identified using the VITEK 2 system, and their antibiotic sensitivity was determined by the 2-fold agar dilution method. Isolates suspected of producing ESBL enzymes were tested by an ESBL phenotypic confirmatory method, and the ESBL genotypes were determined by the polymerase chain reaction and sequencing.

RESULTS

A total of 80 MDR gram-negative strains were isolated from 350 SOT recipients. Among these strains, 42 (52.5%) had an ESBL-positive phenotype; 33 (42.3%) patients with ESBL-positive infection were found. Molecular analysis showed that most of the isolates harbored blaCTX-M-9 (78.6%), blaTEM (81.0%), and blaSHV (69.0%) genes. All the ESBL-producing strains were susceptible to carbapenems.

CONCLUSIONS

MDR gram-negative isolates from SOT recipients are frequently ESBL producers. TEM and CTX-M9 were the predominant ESBL types.

摘要

背景

多重耐药(MDR)革兰氏阴性杆菌对实体器官移植(SOT)受者构成了严重且迅速出现的威胁。然而,超广谱β-内酰胺酶(ESBLs)作为SOT受者对抗菌药物耐药的主要机制之一,仍不清楚。本研究的目的是调查多重耐药革兰氏阴性杆菌感染的SOT患者中产生ESBLs菌株的流行情况,并鉴定它们携带的ESBL基因。

材料与方法

使用VITEK 2系统对SOT受者各种临床标本中的分离株进行鉴定,并通过2倍琼脂稀释法测定其抗生素敏感性。对疑似产生ESBL酶的分离株采用ESBL表型确证方法进行检测,并通过聚合酶链反应和测序确定ESBL基因型。

结果

从350名SOT受者中总共分离出80株多重耐药革兰氏阴性菌株。在这些菌株中,42株(52.5%)具有ESBL阳性表型;发现33例(42.3%)患者感染了ESBL阳性菌株。分子分析表明,大多数分离株携带blaCTX-M-9(78.6%)、blaTEM(81.0%)和blaSHV(69.0%)基因。所有产ESBLs菌株均对碳青霉烯类药物敏感。

结论

来自SOT受者的多重耐药革兰氏阴性分离株经常产生ESBLs。TEM和CTX-M9是主要的ESBL类型。

相似文献

1
Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients.实体器官移植受者中产超广谱β-内酰胺酶(ESBLs)的多重耐药革兰氏阴性杆菌及ESBL基因的患病率。
Transpl Infect Dis. 2013 Feb;15(1):14-21. doi: 10.1111/tid.12001. Epub 2012 Sep 26.
2
Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.沙特阿拉伯一家综合医院耐多药革兰氏阴性菌分离株中广谱β-内酰胺酶的流行情况。
Saudi Med J. 2004 May;25(5):570-4.
3
Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.从眼部感染中分离出的产超广谱β-内酰胺酶革兰氏阴性菌的患病率及抗菌耐药模式
Indian J Ophthalmol. 2016 Apr;64(4):303-11. doi: 10.4103/0301-4738.182943.
4
[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].[土耳其医院革兰氏阴性医院分离株对新型β-内酰胺类及相关超广谱β-内酰胺酶类型的耐药性:多中心HITIT研究结果]
Mikrobiyol Bul. 2008 Oct;42(4):537-44.
5
[Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].[革兰氏阴性菌临床上重要的β-内酰胺酶:超广谱β-内酰胺酶(ESBL)]
Epidemiol Mikrobiol Imunol. 2007 Aug;56(3):103-11.
6
Extended spectrum beta-lactamases among Gram-negative bacteria of nosocomial origin from an intensive care unit of a tertiary health facility in Tanzania.坦桑尼亚一家三级医疗机构重症监护病房医院源性革兰氏阴性菌中的超广谱β-内酰胺酶
BMC Infect Dis. 2005 Oct 15;5:86. doi: 10.1186/1471-2334-5-86.
7
Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.产超广谱β-内酰胺酶革兰阴性杆菌新出现菌株的特征、流行病学及临床重要性
Res Microbiol. 2004 Jul-Aug;155(6):409-21. doi: 10.1016/j.resmic.2004.02.009.
8
Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings.社区环境中产超广谱β-内酰胺酶肠杆菌科细菌和耐碳青霉烯革兰氏阴性杆菌的粪便携带情况。
J Infect Dev Ctries. 2013 Aug 15;7(8):630-4. doi: 10.3855/jidc.2900.
9
Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.在埃塞俄比亚吉姆马,临床分离的革兰氏阴性杆菌中产 CTX-M 型超广谱β-内酰胺酶的流行情况及药敏模式。
BMC Infect Dis. 2018 Oct 20;18(1):524. doi: 10.1186/s12879-018-3436-7.
10
Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).西班牙SMART研究(2002 - 2010年)中腹腔内感染革兰阴性菌的抗菌药敏性及产超广谱β-内酰胺酶分离株的演变
Rev Esp Quimioter. 2011 Dec;24(4):223-32.

引用本文的文献

1
Predicting carbapenem-resistant Enterobacteriaceae infections in pediatric liver transplant recipients.预测小儿肝移植受者碳青霉烯类耐药肠杆菌科细菌感染
World J Pediatr. 2025 Sep 9. doi: 10.1007/s12519-025-00973-9.
2
Extended spectrum beta-lactamase and aminoglycoside modifying enzyme genes in multi drug resistant Gram-negative bacteria: A snapshot from a tertiary care centre.多重耐药革兰氏阴性菌中的超广谱β-内酰胺酶和氨基糖苷类修饰酶基因:来自三级医疗中心的简要情况
Med J Armed Forces India. 2024 Dec;80(Suppl 1):S223-S231. doi: 10.1016/j.mjafi.2023.09.007. Epub 2023 Nov 11.
3
Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients.
实体器官移植患者中抗菌药物耐药性与管理面临的挑战
Curr Infect Dis Rep. 2022;24(5):63-75. doi: 10.1007/s11908-022-00778-1. Epub 2022 Apr 30.
4
Multidrug-resistant organisms: A significant cause of severe sepsis in pediatric intestinal and multi-visceral transplantation.多重耐药菌:小儿肠和多脏器移植术后严重脓毒症的重要原因。
Am J Transplant. 2022 Jan;22(1):122-129. doi: 10.1111/ajt.16756. Epub 2021 Jul 28.
5
High prevalence of multidrug-resistant gram-negative bacterial infection following pediatric liver transplantation.小儿肝移植后多重耐药革兰氏阴性菌感染的高患病率。
Medicine (Baltimore). 2020 Nov 6;99(45):e23169. doi: 10.1097/MD.0000000000023169.
6
Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia.影响耐多药革兰阴性菌血症的腹部实体器官移植受者死亡率的因素。
BMC Infect Dis. 2017 Feb 27;17(1):171. doi: 10.1186/s12879-017-2276-1.
7
C7 genotype of the donor may predict early bacterial infection after liver transplantation.供体的C7基因型可能预测肝移植后的早期细菌感染。
Sci Rep. 2016 Apr 11;6:24121. doi: 10.1038/srep24121.
8
Immunity of fungal infections alleviated graft reject in liver transplantation compared with non-fungus recipients.与非真菌感染受者相比,真菌感染的免疫在肝移植中减轻了移植物排斥反应。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2603-14. eCollection 2015.
9
Bacterial infection after liver transplantation.肝移植后的细菌感染
World J Gastroenterol. 2014 May 28;20(20):6211-20. doi: 10.3748/wjg.v20.i20.6211.
10
Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge.肝移植后多重耐药菌感染:一项日益严峻的挑战。
World J Gastroenterol. 2014 May 28;20(20):6201-10. doi: 10.3748/wjg.v20.i20.6201.